Skip to main content
Log in

A glioblastoma neurosphere line with alternative lengthening of telomeres

  • Correspondence
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR (1995) Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 14:4240–4248

    PubMed  CAS  Google Scholar 

  2. Nguyen DN, Heaphy CM, de Wilde RF, Orr BA, Odia Y, Eberhart CG et al (2012) Molecular and morphologic correlates of the alternative lengthening of telomeres phenotype in high-grade astrocytomas. Brain Pathol. doi:10.1111/j.1750-3639.2012.00630.x

    PubMed  Google Scholar 

  3. Heaphy CM, Subhawong AP, Hong SM, Goggins MG, Montgomery EA, Gabrielson E et al (2011) Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes. Am J Pathol 179:1608–1615

    Article  PubMed  CAS  Google Scholar 

  4. McDonald KL, McDonnell J, Muntoni A, Henson JD, Hegi ME, von Deimling A et al (2010) Presence of alternative lengthening of telomeres mechanism in patients with glioblastoma identifies a less aggressive tumor type with longer survival. J Neuropathol Exp Neurol 69:729–736

    Article  PubMed  Google Scholar 

  5. Silvestre DC, Pineda JR, Hoffschir F, Studler JM, Mouthon MA, Pflumio F et al (2011) Alternative lengthening of telomeres in human glioma stem cells. Stem Cells 29:440–451

    Article  PubMed  CAS  Google Scholar 

  6. Heaphy CM, de Wilde RF, Jiao Y, Klein AP, Edil BH, Shi C et al (2011) Altered telomeres in tumors with ATRX and DAXX mutations. Science 333:425

    Article  PubMed  CAS  Google Scholar 

  7. Schreck KC, Taylor P, Marchionni L, Gopalakrishnan V, Bar EE, Gaiano N et al (2010) The Notch target Hes1 directly modulates Gli1 expression and Hedgehog signaling: a potential mechanism of therapeutic resistance. Clin Cancer Res 16:6060–6070

    Article  PubMed  CAS  Google Scholar 

  8. Min JL, Meulenbelt I, Kloppenburg M, van Duijn CM, Slagboom PE (2007) Mutation analysis of candidate genes within the 2q33.3 linkage area for familial early-onset generalised osteoarthritis. Eur J Hum Genet 15:791–799

    Article  PubMed  CAS  Google Scholar 

  9. Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W et al (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360:765–773

    Article  PubMed  CAS  Google Scholar 

  10. Jiao Y, Killela PJ, Reitman ZJ, Rasheed AB, Heaphy CM, de Wilde RF et al (2012) Frequent ATRX, CIC, and FUBP1 mutations refine the classification of malignant gliomas. Oncotarget 3:709–722

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Alan K. Meeker or Charles G. Eberhart.

Additional information

C. M. Heaphy and K. C. Schreck equally contributed to this study.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Heaphy, C.M., Schreck, K.C., Raabe, E. et al. A glioblastoma neurosphere line with alternative lengthening of telomeres. Acta Neuropathol 126, 607–608 (2013). https://doi.org/10.1007/s00401-013-1174-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00401-013-1174-x

Keywords

Navigation